Andrew Steven Allegretti, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatorenal Syndrome | 19 | 2024 | 76 | 7.910 |
Why?
|
Acute Kidney Injury | 32 | 2024 | 1945 | 6.340 |
Why?
|
Liver Cirrhosis | 25 | 2024 | 1959 | 4.170 |
Why?
|
Vasoconstrictor Agents | 10 | 2024 | 654 | 2.560 |
Why?
|
Hemofiltration | 3 | 2023 | 58 | 2.020 |
Why?
|
Renal Replacement Therapy | 6 | 2024 | 281 | 1.610 |
Why?
|
Liver Transplantation | 13 | 2024 | 2412 | 1.400 |
Why?
|
Lypressin | 6 | 2024 | 26 | 1.390 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2021 | 95 | 1.220 |
Why?
|
Renal Insufficiency, Chronic | 15 | 2024 | 2309 | 1.140 |
Why?
|
Kidney Failure, Chronic | 8 | 2024 | 2495 | 1.060 |
Why?
|
Hypokalemic Periodic Paralysis | 1 | 2024 | 7 | 0.920 |
Why?
|
Glomerular Filtration Rate | 11 | 2024 | 2233 | 0.880 |
Why?
|
Thyrotoxicosis | 1 | 2024 | 85 | 0.860 |
Why?
|
Renal Dialysis | 5 | 2020 | 1799 | 0.810 |
Why?
|
Muscle Weakness | 1 | 2024 | 412 | 0.730 |
Why?
|
Micropore Filters | 1 | 2020 | 23 | 0.720 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 62 | 0.720 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.660 |
Why?
|
Pyrans | 1 | 2019 | 47 | 0.640 |
Why?
|
Patient Care Planning | 1 | 2024 | 906 | 0.600 |
Why?
|
Cholestasis | 1 | 2021 | 386 | 0.590 |
Why?
|
Waiting Lists | 4 | 2024 | 777 | 0.580 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 187 | 0.570 |
Why?
|
Sickle Cell Trait | 4 | 2021 | 86 | 0.510 |
Why?
|
Paracentesis | 1 | 2016 | 99 | 0.500 |
Why?
|
Critical Illness | 4 | 2024 | 2744 | 0.480 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 280 | 0.480 |
Why?
|
Drug Monitoring | 1 | 2020 | 961 | 0.460 |
Why?
|
Lectins | 1 | 2016 | 487 | 0.460 |
Why?
|
Acid-Base Equilibrium | 1 | 2015 | 180 | 0.450 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.440 |
Why?
|
Bicarbonates | 1 | 2015 | 292 | 0.440 |
Why?
|
Heparin | 1 | 2020 | 1630 | 0.420 |
Why?
|
End Stage Liver Disease | 6 | 2024 | 369 | 0.420 |
Why?
|
Liver Diseases | 1 | 2021 | 1303 | 0.400 |
Why?
|
Calciphylaxis | 1 | 2014 | 129 | 0.390 |
Why?
|
Creatinine | 4 | 2024 | 1915 | 0.390 |
Why?
|
Kidney | 7 | 2023 | 7066 | 0.370 |
Why?
|
Tissue and Organ Harvesting | 1 | 2014 | 373 | 0.370 |
Why?
|
Hepatitis, Alcoholic | 2 | 2024 | 109 | 0.360 |
Why?
|
Serum Albumin | 2 | 2024 | 676 | 0.340 |
Why?
|
Humans | 76 | 2024 | 765734 | 0.340 |
Why?
|
Living Donors | 1 | 2014 | 645 | 0.330 |
Why?
|
Intensive Care Units | 3 | 2023 | 3800 | 0.330 |
Why?
|
Prognosis | 13 | 2024 | 29899 | 0.320 |
Why?
|
Hyponatremia | 2 | 2023 | 278 | 0.310 |
Why?
|
Middle Aged | 35 | 2024 | 222903 | 0.290 |
Why?
|
Anemia, Sickle Cell | 3 | 2021 | 1062 | 0.280 |
Why?
|
Albumins | 2 | 2022 | 577 | 0.280 |
Why?
|
Male | 42 | 2024 | 363585 | 0.270 |
Why?
|
Chronic Disease | 3 | 2019 | 9351 | 0.250 |
Why?
|
Aged | 30 | 2024 | 171050 | 0.250 |
Why?
|
Gastric Bypass | 1 | 2014 | 820 | 0.250 |
Why?
|
Nurses | 1 | 2015 | 2505 | 0.250 |
Why?
|
Female | 40 | 2024 | 395961 | 0.230 |
Why?
|
Severity of Illness Index | 9 | 2024 | 15883 | 0.230 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2023 | 17 | 0.220 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2709 | 0.210 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1293 | 0.210 |
Why?
|
Hypokalemia | 1 | 2024 | 154 | 0.210 |
Why?
|
Tremor | 1 | 2024 | 197 | 0.210 |
Why?
|
Cystatin C | 1 | 2024 | 272 | 0.210 |
Why?
|
Kidney Tubules, Proximal | 1 | 2024 | 387 | 0.200 |
Why?
|
Prospective Studies | 10 | 2024 | 54795 | 0.200 |
Why?
|
Taste Disorders | 1 | 2022 | 37 | 0.190 |
Why?
|
Low Back Pain | 1 | 2010 | 987 | 0.190 |
Why?
|
Epidermal Growth Factor | 1 | 2024 | 698 | 0.190 |
Why?
|
Liver Failure | 1 | 2024 | 252 | 0.190 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2021 | 64 | 0.190 |
Why?
|
Exercise | 1 | 2018 | 5937 | 0.180 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2021 | 64 | 0.180 |
Why?
|
Arm | 1 | 2024 | 588 | 0.180 |
Why?
|
Feces | 2 | 2017 | 1504 | 0.180 |
Why?
|
Clostridium Infections | 2 | 2017 | 564 | 0.180 |
Why?
|
Treatment Outcome | 10 | 2024 | 65180 | 0.180 |
Why?
|
Receptors, Purinergic P2Y | 1 | 2020 | 23 | 0.180 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4269 | 0.180 |
Why?
|
Adult | 24 | 2024 | 222974 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4057 | 0.170 |
Why?
|
Vancomycin | 1 | 2023 | 504 | 0.170 |
Why?
|
Retrospective Studies | 16 | 2024 | 81457 | 0.170 |
Why?
|
Ferrosoferric Oxide | 1 | 2021 | 349 | 0.160 |
Why?
|
Physicians | 2 | 2015 | 4587 | 0.160 |
Why?
|
Factor Xa | 1 | 2020 | 166 | 0.160 |
Why?
|
Clinical Competence | 1 | 2015 | 4862 | 0.160 |
Why?
|
Olfaction Disorders | 1 | 2022 | 223 | 0.160 |
Why?
|
Esophageal and Gastric Varices | 1 | 2021 | 215 | 0.160 |
Why?
|
Leg | 1 | 2024 | 1080 | 0.160 |
Why?
|
Hypertension, Portal | 1 | 2021 | 229 | 0.160 |
Why?
|
Bile Acids and Salts | 1 | 2021 | 398 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12949 | 0.150 |
Why?
|
Thyroidectomy | 1 | 2024 | 911 | 0.150 |
Why?
|
Communication | 2 | 2024 | 3914 | 0.150 |
Why?
|
Fibrosis | 2 | 2023 | 2068 | 0.150 |
Why?
|
Equipment Failure Analysis | 1 | 2020 | 834 | 0.150 |
Why?
|
Sodium | 2 | 2023 | 1591 | 0.150 |
Why?
|
Health Resources | 1 | 2024 | 949 | 0.140 |
Why?
|
Cohort Studies | 8 | 2024 | 41631 | 0.140 |
Why?
|
DNA, Bacterial | 2 | 2019 | 1476 | 0.140 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3278 | 0.140 |
Why?
|
Massachusetts | 3 | 2019 | 8876 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3926 | 0.130 |
Why?
|
Case-Control Studies | 5 | 2024 | 22224 | 0.130 |
Why?
|
Risk Factors | 10 | 2024 | 74831 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12238 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1441 | 0.120 |
Why?
|
Liver Failure, Acute | 1 | 2016 | 183 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1100 | 0.120 |
Why?
|
Elastic Modulus | 1 | 2015 | 208 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2020 | 1166 | 0.110 |
Why?
|
Disease Progression | 5 | 2023 | 13614 | 0.110 |
Why?
|
Magnetic Resonance Angiography | 1 | 2021 | 1426 | 0.110 |
Why?
|
Proxy | 1 | 2015 | 151 | 0.110 |
Why?
|
Poison Control Centers | 1 | 2014 | 76 | 0.110 |
Why?
|
Carrier State | 1 | 2017 | 529 | 0.110 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2017 | 333 | 0.110 |
Why?
|
Length of Stay | 2 | 2020 | 6487 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1510 | 0.110 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1274 | 0.100 |
Why?
|
Hemoglobins | 1 | 2019 | 1528 | 0.100 |
Why?
|
Bumetanide | 1 | 2013 | 101 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2020 | 5343 | 0.100 |
Why?
|
Poisoning | 1 | 2014 | 254 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2710 | 0.100 |
Why?
|
Hospital Charges | 1 | 2014 | 345 | 0.100 |
Why?
|
Postoperative Complications | 1 | 2014 | 15749 | 0.090 |
Why?
|
Ischemia | 1 | 2020 | 1910 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2024 | 3425 | 0.090 |
Why?
|
Hip Fractures | 1 | 2019 | 997 | 0.090 |
Why?
|
Ascites | 2 | 2024 | 336 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2017 | 1069 | 0.090 |
Why?
|
Carbon Dioxide | 1 | 2015 | 1137 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1316 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2477 | 0.080 |
Why?
|
Diuretics | 1 | 2013 | 613 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3230 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2014 | 1831 | 0.080 |
Why?
|
Neoplasms | 1 | 2018 | 22345 | 0.080 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4961 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10069 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10730 | 0.080 |
Why?
|
Time Factors | 3 | 2024 | 40066 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2017 | 2033 | 0.070 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12509 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20120 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3286 | 0.060 |
Why?
|
Hospitalization | 3 | 2024 | 10806 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2019 | 12433 | 0.060 |
Why?
|
United States | 6 | 2024 | 72898 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7477 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4862 | 0.060 |
Why?
|
Iothalamic Acid | 1 | 2024 | 18 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5088 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4081 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5891 | 0.060 |
Why?
|
Patients | 1 | 2010 | 910 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10385 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12056 | 0.050 |
Why?
|
Texas | 1 | 2024 | 410 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10567 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2010 | 2740 | 0.050 |
Why?
|
Sepsis | 1 | 2016 | 2601 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18375 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8626 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2010 | 1458 | 0.040 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 113 | 0.040 |
Why?
|
Survival Rate | 3 | 2024 | 12787 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1613 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36537 | 0.040 |
Why?
|
Extracellular Fluid | 1 | 2019 | 165 | 0.040 |
Why?
|
Midodrine | 1 | 2017 | 24 | 0.040 |
Why?
|
Indiana | 1 | 2017 | 93 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2020 | 394 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59459 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15648 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3423 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2022 | 1178 | 0.030 |
Why?
|
Octreotide | 1 | 2017 | 157 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39180 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 956 | 0.030 |
Why?
|
Gadolinium | 1 | 2021 | 965 | 0.030 |
Why?
|
Metagenomics | 1 | 2019 | 473 | 0.030 |
Why?
|
Norepinephrine | 1 | 2017 | 899 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1043 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3200 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1127 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2017 | 1077 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8732 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2019 | 933 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3229 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26284 | 0.030 |
Why?
|
Elasticity | 1 | 2015 | 652 | 0.030 |
Why?
|
Nephrotic Syndrome | 1 | 2017 | 380 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7232 | 0.020 |
Why?
|
International Cooperation | 1 | 2018 | 1432 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2717 | 0.020 |
Why?
|
Patient Selection | 1 | 2024 | 4254 | 0.020 |
Why?
|
Treatment Failure | 1 | 2017 | 2653 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2594 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2965 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1217 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 17531 | 0.020 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 398 | 0.020 |
Why?
|
Dopamine | 1 | 2017 | 1583 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2904 | 0.020 |
Why?
|
Colonoscopy | 1 | 2017 | 1406 | 0.020 |
Why?
|
Cost Savings | 1 | 2014 | 904 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2229 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24279 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6061 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15390 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5326 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3772 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3563 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2017 | 2097 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8498 | 0.010 |
Why?
|
Incidence | 1 | 2023 | 21478 | 0.010 |
Why?
|
Sex Factors | 1 | 2019 | 10605 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2020 | 14445 | 0.010 |
Why?
|
Prevalence | 1 | 2022 | 15833 | 0.010 |
Why?
|
Ultrasonography | 1 | 2017 | 5986 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8293 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 59852 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 88781 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14061 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1992 | 6356 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20667 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2014 | 26332 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81792 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1992 | 6952 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36363 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42468 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168731 | 0.000 |
Why?
|
Child | 1 | 2014 | 80499 | 0.000 |
Why?
|